Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

iBio Is Now Lagging in Another Area

By Larry Ramer, InvestorPlace Contributor

iBio's leading vaccine and its therapy appear to be too far behind the competition to generate much revenue for IBIO stock.

4 Pharmaceutical Stocks With Deep Pipelines

By Larry Ramer, InvestorPlace Contributor

Coronavirus vaccines get all the attention, but these four pharmaceutical stocks benefit from equipment, drug and test kit developments.

Sorrento’s Covid-19 Test, Acquisitions Should Help SRNE Stock Surge

By Larry Ramer, InvestorPlace Contributor

Sorrento's COVID-19 test appears to be superior to competing diagnostics, and it just made a good acquisition, while its overall strategy is sound.

Contracts in Developing Countries Bode Well for GE Stock

By Larry Ramer, InvestorPlace Contributor

Recent developments show that developing countries are upgrading their electrical equipment ,while developed nations will have to continue to rely on natural gas. Those trends are positive for GE stock.

Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally

By Larry Ramer, InvestorPlace Contributor

Strong sales of Gilead's successful novel coronavirus drug, remdesivir, will ultimately lift GILD stock and reward shareholders.

As a TikTok Deal Nears, Innovative Fastly Stock Is Still Looking Good

By Larry Ramer, InvestorPlace Contributor

The valuation of FSLY stock is not overdone, given the company's competitive advantages

The Long-Term Outlook of Snap Stock Remains Bright

By Larry Ramer, InvestorPlace Contributor

Snap stock should thrive after the Covid-19 pandemic as marketers look to capture consumers' pent-up demand for goods and services.

Several Strong Catalysts Can Take Plug Power Stock Much Higher

By Larry Ramer, InvestorPlace Contributor

Plug Power looks poised to continue to benefit from the e-commerce explosion and the proliferation of hydrogen trucks. Those should 'fuel' PLUG stock gains.

5 Stocks Set To Surge If Congress Passes Second Stimulus

By Larry Ramer, InvestorPlace Contributor

Here are five stocks to buy for investors who want to benefit from potential new economic stimulus measures.

Amid Looming Threats, Avoid Nvidia Stock

By Larry Ramer, InvestorPlace Contributor

Nvidia's data center and gaming businesses appear to be facing a looming threat from Intel. Investors should avoid Nvidia stock.

Load More